Search -

Displaying 381 - 400 of 414

Sort: Relevancy | Date

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Industry News

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

June 24, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Yael L. Maxwell

June 03, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Industry News

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

May 19, 2015

News Daily News

Techniques to Lower Radiation Dose in TAVR Feasible

L.A. McKeown

May 13, 2015

News Daily News

Técnicas Viables para Minimizar la Dosis de Radiación durante la realización de TAVR

L.A. McKeown

May 13, 2015

News Daily News

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Yael L. Maxwell

February 09, 2015

News Daily News

Michael J. Davidson, Advocate of Surgical-Interventional Cooperation, Dies at 44

Yael L. Maxwell

January 28, 2015

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Valvular Migration During TAVR

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Ganesh Manoharan

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

Aortic Regurgitation Confirmed as Powerful Mortality Predictor after TAVR

L.A. McKeown

March 05, 2014

Presentation TCT 2013

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

Presenter: Helene Eltchaninoff

October 31, 2013

Presentation TCT 2013

The Case for a Hybrid OR-Cath Lab for TAVR Procedures

Presenter: Alan Lumsden

October 28, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

Advertisement

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

LV Flow After TAVR Predicts Late Mortality

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

Techniques to Lower Radiation Dose in TAVR Feasible

Técnicas Viables para Minimizar la Dosis de Radiación durante la realización de TAVR

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Michael J. Davidson, Advocate of Surgical-Interventional Cooperation, Dies at 44

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Valvular Migration During TAVR

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

Aortic Regurgitation Confirmed as Powerful Mortality Predictor after TAVR

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

The Case for a Hybrid OR-Cath Lab for TAVR Procedures

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content